| Summary of cash, cash equivalents, restricted cash equivalents and marketable securities |
The following tables summarize the amortized cost and fair value of the Company's cash equivalents, restricted cash equivalents and marketable securities by major investment category (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2026 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Estimated Fair Value |
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
2,472 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,472 |
|
Restricted cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
200 |
|
|
|
— |
|
|
|
— |
|
|
|
200 |
|
Total cash equivalents and restricted cash equivalents |
|
|
2,672 |
|
|
|
— |
|
|
|
— |
|
|
|
2,672 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasuries and agencies |
|
|
38,305 |
|
|
|
— |
|
|
|
(29 |
) |
|
|
38,276 |
|
Corporate debt securities |
|
|
7,302 |
|
|
|
— |
|
|
|
(7 |
) |
|
|
7,295 |
|
Commercial paper |
|
|
2,955 |
|
|
|
— |
|
|
|
(3 |
) |
|
|
2,952 |
|
Total marketable securities |
|
|
48,562 |
|
|
|
— |
|
|
|
(39 |
) |
|
|
48,523 |
|
Total cash equivalents, restricted cash equivalents and marketable securities |
|
$ |
51,234 |
|
|
$ |
— |
|
|
$ |
(39 |
) |
|
$ |
51,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Estimated Fair Value |
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
6,757 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,757 |
|
U.S. Treasuries and agencies |
|
|
6,891 |
|
|
|
— |
|
|
|
— |
|
|
|
6,891 |
|
Commercial paper |
|
|
2,099 |
|
|
|
— |
|
|
|
— |
|
|
|
2,099 |
|
Corporate debt securities |
|
|
1,491 |
|
|
|
— |
|
|
|
— |
|
|
|
1,491 |
|
Total cash equivalents |
|
|
17,238 |
|
|
|
— |
|
|
|
— |
|
|
|
17,238 |
|
Restricted cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
200 |
|
|
|
— |
|
|
|
— |
|
|
|
200 |
|
Total cash equivalents and restricted cash equivalents |
|
|
17,438 |
|
|
|
— |
|
|
|
— |
|
|
|
17,438 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasuries and agencies |
|
|
25,868 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
25,867 |
|
Corporate debt securities |
|
|
3,233 |
|
|
|
— |
|
|
|
— |
|
|
|
3,233 |
|
Commercial paper |
|
|
1,991 |
|
|
|
— |
|
|
|
— |
|
|
|
1,991 |
|
Total marketable securities |
|
|
31,092 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
31,091 |
|
Total cash equivalents, restricted cash equivalents and marketable securities |
|
$ |
48,530 |
|
|
$ |
2 |
|
|
$ |
(3 |
) |
|
$ |
48,529 |
|
|